Therefore, we hypothesized that the inhibition of PLK1 alone would have an anti-fibrotic effect without suppressing the recovery of lung epithelial cells from injury and examined the anti-fibrotic effect of GSK461364, a selective PLK1 inhibitor, in a mouse model of bleomycin-induced pulmonary fibrosis. Here, PLK1 is linked to pulmonary fibrosis.